Differences

This shows you the differences between two versions of the page.

--- cardio:heart_failure:start [2026/02/13 00:03] – [The Neurohormonal Model] andrew2393cns
+++ cardio:heart_failure:start [2026/02/13 18:00] (current) – [Diuretics (Symptom Control)] andrew2393cns
@@ Line 95: / Line 95: @@
 These therapies reduce mortality and hospitalization.
+----
 ==== RAAS Inhibition ====
@@ Line 188: / Line 187: @@
 Used for congestion relief:
-• [[cardio:diuretics:furosemide|Furosemide]]
+  * • [[cardio:diuretics:furosemide|Furosemide]]
-• [[cardio:diuretics:torsemide|Torsemide]]
+  * • [[cardio:diuretics:torsemide|Torsemide]]
 Effect:
-• ↓ Preload
+  * • ↓ Preload
-• ↓ Pulmonary edema
+  * • ↓ Pulmonary edema
-• Symptom improvement only
+  * • Symptom improvement only
 --------------------------------------------------------------------
@@ Line 243: / Line 242: @@
 ==== Clinical Pearls ====
-✔ Heart failure is a neurohormonal disease
+  * ✔ Heart failure is a neurohormonal disease
-✔ Diuretics improve symptoms, not survival
+  * ✔ Diuretics improve symptoms, not survival
-✔ Four pillars reduce mortality
+  * ✔ Four pillars reduce mortality
-✔ Only specific beta-blockers reduce mortality
+  * ✔ Only specific beta-blockers reduce mortality
-✔ SGLT2 inhibitors benefit even non-diabetics
+  * ✔ SGLT2 inhibitors benefit even non-diabetics
-✔ Start low, titrate slowly
+  * ✔ Start low, titrate slowly
 --------------------------------------------------------------------